相关实验视频

Updated: May 8, 2026

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

scDiffCoAM:使用scRNA-Seq数据分析来识别食道状细胞癌的潜在生物标志物的完整框架

Manaswita Saikia¹, Dhruba K Bhattacharyya, Jugal K Kalita

¹Department of Computer Science and Engineering, Tezpur University, Napaam, Tezpur 784028, Assam, India.

Journal of biosciences

|August 9, 2024

概括

这项研究引入了scDiffCoAM,这是一种用于分析稀疏单细胞RNA测序数据的新框架,以识别食道状细胞癌等疾病中的基因网络模块和潜在生物标志物.

科学领域:

基因组学就是基因组学.
生物信息学是一种生物信息学.
计算生物学计算生物学

背景情况:

单细胞RNA测序 (scRNA-Seq) 提供了关于细胞过程和基因相互作用的见解.
在scRNA-Seq中数据稀缺性带来了重大的分析挑战.

研究的目的:

为scRNA-Seq数据开发一个强大的差异共同表达 (DCE) 分析框架.
从稀疏的scRNA-Seq数据集中识别网络模块和潜在的枢纽基因 (生物标志物).

主要方法:

提出了一个名为scDiffCoAM.的完整差异共同表达 (DCE) 分析框架.
使用食道状细胞癌 (ESCC) 的scRNA-Seq数据集验证了框架.
将scDiffCoAM与四种现有的枢纽基因识别方法进行比较.

主要成果:

scDiffCoAM框架在ESCC数据集上表现出令人满意的表现.
在识别独特的潜在生物标志物方面,scDiffCoAM的表现优于现有的方法.
识别的生物标志物在统计和生物学上都得到了验证.

结论:

scDiffCoAM是一种有效的方法来分析稀疏的scRNA-Seq数据.
该框架成功地确定了疾病的新型潜在生物标志物.
这种方法增强了对细胞异质性中的基因相互作用的理解.

更多相关视频

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

相关概念视频

RNA-seq

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...